Center for Bioethics Papers
Document Type
Journal Article
Date of this Version
September 2003
Abstract
Despite ethical concerns about gene patents, virtually no empirical evidence exists to support claims about either positive or negative effects, and extremely little is known about the intellectual property protection strategies of firms and universities. This article discusses the results of a pilot study to examine patenting and licensing philosophies, policies, and practices of different types of institutions and to describe the contractual conditions for licensing DNA sequence inventions.
COinS
Date Posted: 21 May 2007
This document has been peer reviewed.
Comments
Postprint version. Published in Journal of Law, Medicine and Ethics, Volume 31, Issue 3, Fall 2003, pages 442-448.
Publisher URL: http://dx.doi.org/10.1111/j.1748-720X.2003.tb00107.x